Metraipolis › archive › dc_631beca58672
Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42401937
- DOI
- 10.1186/s13048-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T11:20:15.845Z
- SHA-256 of the archived text
2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d- Stable URL of this page
https://metraipolis.com/documento/dc_631beca58672
How to cite
Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937 — Europe PMC (en), https://europepmc.org/article/MED/42401937 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_631beca58672 (Metraipolis archive dc_631beca58672, sha256 2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d)
BibTeX
@misc{dc631beca58672,
title = {Acetylation in ovarian cancer: mechanistic insights into drug resistance and emerging therapeutic opportunities — Europe PMC PMID:42401937},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42401937},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_631beca58672; sha256 2f355143cc7867627cb5ea8ada7d4ce0f0cab5608e98d99037a0ac6689abd65d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42401937. Agents can read the archived copy with the MCP tool read_document.